FDA/EU compliance information available upon request Mevopur™ Healthcare Colorants and Formulations for Ophthalmic Closures The Mevopur™ range of standard concentrates for closures used with ocular (ophthalmic) medicines matches the color standards from the American Academy of Ophthalmology (AAO). Custom pre-colored formulations can be developed in other resins upon customer request. KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified manufacturing sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal- derived substances • Standard concentrates in a PE carrier and on request in PP • Pre-colored formulations can be supplied in specific resins selected for the application REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) • Food contact established with FDA/EU* APPLICATION BULLETIN DRUG TYPE COLOR DESCRIPTION PANTONE REFERENCE AVIENT PRODUCT CODE PE BASED Adrenergic agonist combinations Light Green 373 C PE6M176349 Adrenergic agonists Purple 2583 C PE4M176057 Anti-infectives Tan 467 C PE8M176130 Anti-inflammatory, nonsteroidal Grey Cool Grey 4 C PE7M176184 steroids Pink 197 C PE3M176237 Anti-inflammatory, immunomodulators Olive Green 5763 C On request Beta-blockers Yellow Yellow C PE1M176160 Beta-blocker combinations Dark Blue 281 C PE5M176272 Carbonic anhydrase inhibitors Orange 1585 C PE2M176089 Cytotoxic Black 6 C PL9M176008 Miotics Dark Green 348 C PE6M176267 Mydriatics and cycloplegics Red 1797 C PE3M176236 Prostaglandin analogues Turquoise 326 C PE5M176273 Healthcare use limitations apply—see below.

Formulated using a proprietary process, Shades of Nature special effects colorants deliver a less industrial effect, appearing more sustainable and handcrafted to enable products to make a sensory connection with consumers. Available in masterbatch solutions, these beautiful effects are formulated with: • organic waste materials, such as almond shells • glitter flakes • synthetic fibers • special effects, such as speckles and pearlescents KEY CHARACTERISTICS • Available in standard or custom finishes • Cost effective replacement for marble, granite, and other expensive and heavy materials across many applications • No additional production investment required MARKETS AND APPLICATIONS Shades of Nature colorants can add depth and dimension to: • Packaging – including premium cosmetics or luxury caps and closures • Transportation – interior or exterior automotive trim and components • Consumer goods – toys, outdoor goods, furniture • Small and large household appliances PRODUCT BULLETIN NAME COLOR TONE EFFECTS EU FDA TOYS T STABILITY Fossil Beige Fibers/Speckles YES NO YES 280°C Lavender Purple Blue Fibers YES NO YES 280°C Rosewood Light Pink Fibers NO NO NO 280°C Emerald Creek Green Special Effects YES YES YES 280°C Mother of Pearl White Pearl Special Effects YES YES YES 280°C Invigorate Yellow Green Natural Waste NO NO YES < 210°C Interstellar Brown Special Effects YES YES YES 280°C Unrefined Grey Glitter NO NO NO 230°C Reflection Blue Glitter NO NO NO 230°C Coral Sand Orange Fibers NO NO NO 280°C REGULATORY INFORMATION IMPORTANT NOTE The above technical and regulatory information is based on the formulation of the current 10 colors in the palette.

Sincerely, Brett Warland Director of Process Improvement PolyOne Corporate PolyOne Quality Survey Standard Response 2015 12 09 Source: Corporate Quality Page: 2 of 14 Table of Contents 1.0 POLYONE CORPORATE: OVERVIEW ................................................................................................................................... 3 2.0 MANAGEMENT SYSTEM REGISTRATIONS .......................................................................................................................... 3 3.0 AUDIT ................................................................................................................................................................................ 3 4.0 MANAGEMENT RESPONSIBILITY ........................................................................................................................................ 4 5.0 QUALITY OVERVIEW .......................................................................................................................................................... 5 5.1 QUALITY MANAGEMENT SYSTEM ................................................................................................................................................. 7 5.2 SUPPLIER MANAGEMENT ............................................................................................................................................................ 7 5.3 DELIVERY ................................................................................................................................................................................. 8 5.4 SYSTEMS, POLICIES, AND PRACTICES .............................................................................................................................................. 9 5.5 RESPONSIVENESS ....................................................................................................................................................................... 9 5.6 TECHNOLOGY.......................................................................................................................................................................... 10 6.0 INFORMATION TECHNOLOGY DISASTER RECOVERY PRACTICES....................................................................................... 11 7.0 ENVIRONMENTAL MANAGEMENT SYSTEM / ISO 14001 .................................................................................................. 14 8.0 CREDIT REFERENCES ........................................................................................................................................................ 14 9.0 SUSTAINABILITY AND NO SURPRISES PLEDGE .................................................................................................................. 14 PolyOne Quality Survey Standard Response 2015 12 09 Source: Corporate Quality Page: 3 of 14 1.0 PolyOne Corporate: Overview • To view the PolyOne Executive Leadership Team and the PolyOne Business Leadership, please visit the following URL: http://www.polyone.com/company/about-us/company-officers Corporate Department of Continuous Improvement (Quality Department) Brett Warland Director of Process Improvement 440-930-3318 Jake Kucbel Corporate Quality Engineer 440-930-1557 SIC / NAICS Codes and Descriptions for PolyOne Businesses 3087 325991 Customer compounding of purchased resins 2821 325211 Plastic material and resin manufacturing 2851 325510 Paint and coating manufacturing (Specialty Coatings) 5162 422610 Plastic materials wholesalers (POD) 326199 Composites (Glasforms) DUNS# 84-508-2861 PolyOne Corporate at PolyOne Center Federal ID# 34-1730488 • Company Longevity: As PolyOne, since 9/1/2000. The "owner" is the person or authority who originally developed the formulation. 6.

BATTERY RANGE EXTENSION Lightweighting SOLUTION: Long fiber reinforced polyketone (PK) thermoplastics © 2023, All Rights Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 https://www.avient.com/products/long-fiber-technology/long-fiber-technologies/compl-t-rec-formulations https://www.avient.com/products/long-fiber-technology/long-fiber-technologies/compl-t-rec-formulations https://www.avient.com/products/long-fiber-technology/complet-moisture-resistant-nylons https://www.avient.com/products/long-fiber-technology/complet-moisture-resistant-nylons

MEDICAL EQUIPMENT MANUFACTURER C L O S E D S Y S T E M D R U G T R A N S F E R D E V I C E • A new material for a seal inside the next generation of closed system drug transfer device • Compliance with stringent regulatory standards: • Biocompatibility to ISO10993 • USP VI compliance • Provided regulatory support services and expertise throughout extensive medical approval process • Provided a custom formulation compliant with the highest healthcare regulatory standards • Enabled material to be manufactured and shipped globally Custom Versalloy™ HC 9220-90 Formulation KEY REQUIREMENTS WHY AVIENT?

SECURITY EQUIPMENT MANUFACTURER B O D Y S C A N N E R • Replace PMMA based radome material • Consistent dielectric performance across large sheet/surface area (4mm thick, 2m high) • Ultra low losses • No defects across full surface area • High resolution imaging to show small illegal objects • Formulated a custom material to match customer requirements • Reduced dielectric loss to 0.0009 • Improved image quality of body scanner with uniform dielectric performance and exceptionally low losses • Enabled scan time of 2 seconds and person throughput of 400 persons per hour, compared to 100 person throughput of conventional devices PREPERM™ PPE 260 Formulation KEY REQUIREMENTS WHY AVIENT?

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks, including recessionary conditions; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without limitation, any supply chain and logistics issues; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; any material adverse changes in the Dyneema Business; our ability to achieve the strategic and other objectives relating to the Acquisition, and the possible sale of the Distribution business segment; and other factors described in our Annual Report on Form 10-K for the year ended

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include the impact the COVID-19 pandemic has on our business, results from operations, financial condition and liquidity; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Masterbatch business, including any expected synergies; our ability to successfully integrate Clariant's Masterbatch business and achieve the expected results of the acquisition of Clariant's Masterbatch business, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to continue to pay cash dividends including at the increased rate; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisitions and integration, working capital reductions, costs reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.

These fibers reinforce a wide array of resin systems ranging from polyamides to higher-performance engineering polymers such as PEEK.

PolyOne Corporation, with 2018 revenues of $3.5 billion, is a premier provider of specialized polymer materials, services and solutions.